Donovan Michael Glancy
CIK: 0002134015
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COLL
COLLEGIUM PHARMACEUTICAL, INC
Director
Discretionary Trading P&L
Holdings
About Glancy Donovan Michael
Glancy Donovan Michael (SEC CIK 0002134015) files insider reports with the SEC as Director of COLLEGIUM PHARMACEUTICAL, INC (COLL).
Signal8 holds 2 ownership filings by Glancy Donovan Michael (1 Form 3, 1 Form 4), filed on May 18, 2026. Those filings report 1 transaction, the latest on May 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Glancy Donovan Michael's filings is in STOUGHTON, MA.
Recent filings by Glancy Donovan Michael
- May 14, 2026: Grant or award of COLL shares (Form 4, code A).
Other insiders filing for COLLEGIUM PHARMACEUTICAL, INC (COLL)
- SANTINI GINO, Director
- Freund John Gordon, Director
- Lurker Nancy, Director
- Paya Carlos V, Director
- BOHLIN GAREN G, Director
- Balice-Gordon Rita J., Director